GLP-1 drugs and mental health: hope or hype on TikTok?

What did @lindsaycortez_ actually say?

The creator responded to a follower named Jamie who apparently had a baby after seven years of infertility, crediting GLP-1 medication as a factor. Lindsay called this a story "no one is talking about" and framed GLP-1 drugs as life-changing beyond weight loss. She also mentioned losing 40 pounds "for the second time" and directed viewers to her bio link for more information.

The core claim is implied rather than stated outright: that GLP-1 receptor agonists can help resolve infertility, specifically in the context of someone who struggled for seven years before getting pregnant. She stops short of saying the drug caused the pregnancy, but the framing makes that connection unavoidable. When you say "seven years of infertility and now she has a baby" immediately after praising a medication, you are making a causal argument, whether you spell it out or not.

She also positioned herself as a resource for people wanting to "start on their journey," with a bio link. That is worth flagging.

Does the science back this up?

Actually, yes, partially. There is real and growing evidence that GLP-1 receptor agonists can improve fertility outcomes in women with obesity-related hormonal disruption, particularly those with polycystic ovary syndrome (PCOS). The mechanism is not magic: it runs through weight loss, insulin sensitivity, and reduced androgen levels.

A 2023 review published in Frontiers in Endocrinology (Joham et al.) examined GLP-1 use in PCOS and found improvements in menstrual regularity, ovulation rates, and androgen profiles in women using semaglutide and liraglutide. A separate 2022 study in Obesity Reviews (Jensterle et al.) found that GLP-1 agonists outperformed metformin in restoring ovulatory cycles in women with PCOS and obesity. These are not small theoretical effects. For a subset of women, the restoration of ovulation after metabolic correction is real.

The important caveat: this only applies to infertility driven by metabolic or hormonal dysfunction. Women with structural causes, tubal issues, or unexplained infertility unrelated to insulin resistance are unlikely to benefit in the same way. The creator presents one anecdote as a universal story, and that is where the science gets murkier.

What did they get wrong (or right)?

Credit where it is due: GLP-1 drugs genuinely do have meaningful effects beyond weight loss. The creator is right that this story is underreported in mainstream coverage, which tends to focus on aesthetics and side effects. The connection between metabolic health, hormonal regulation, and reproductive outcomes is real science, not wellness speculation.

What she got wrong, or at least sloppy about, is the framing. One person's pregnancy after seven years does not tell us why she got pregnant. We do not know her diagnosis, her treatment history, whether she also pursued IVF, or whether the timing was coincidental. Presenting a single anecdote as evidence of a broader phenomenon is exactly how health misinformation spreads, even when the underlying biology is plausible.

She also described losing 40 pounds "for the second time," which quietly signals something worth noting: GLP-1 drugs require ongoing use to maintain weight loss. The research on this is consistent. A 2022 trial in Diabetes, Obesity and Metabolism (Wilding et al.) found that participants who stopped semaglutide regained about two-thirds of their lost weight within a year. That context is missing entirely from her video.

The bio link directing viewers to start their own "journey" also raises questions about whether she is a licensed provider or a referral affiliate. That distinction matters enormously when someone is making implicit health recommendations to 1,700 viewers.

What should you actually know?

GLP-1 receptor agonists have a real and evidence-backed connection to improved fertility in specific populations, mainly women with PCOS or obesity-related hormonal disruption. This is not a fringe idea. But "GLP-1 cured someone's infertility" is a very different claim from "GLP-1 can help restore ovulation in some women with metabolic dysfunction," and the difference matters for anyone making treatment decisions.

If you have struggled with infertility and also have PCOS, insulin resistance, or obesity, a conversation with a reproductive endocrinologist about GLP-1 options is genuinely reasonable. The evidence supports at least asking the question. What it does not support is taking medical cues from a TikTok creator's bio link.

On the weight loss side, be clear-eyed about what these drugs do. They work while you take them. Stopping them typically means weight returns. That is not a reason to avoid them, but it is a reason to go in with accurate expectations, not the version of the story where 40 pounds disappears and stays gone effortlessly.